Straumann Emdogain
FDA premarket approval P930021/S028 · decided 2023-04-04
Approval details
- PMA number
- P930021
- Supplement
- S028
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Straumann Emdogain
- Generic name
- Biologic material, dental
- Applicant
- The Straumann Company
- Date received
- 2021-12-10
- Decision date
- 2023-04-04
- Days to decision
- 480 days
- Decision code
- APPR
- Product code
- NQA
- Advisory committee
- Dental
- Expedited review
- No
- Location
- Andover, MA
- Statement
- Approval for the implementation of a new freeze room and a new cold room to increase storage capacity for raw materials, and intermediate and final products.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.